GlycoMimetics Inc. (GLYC) - Rasio kapitalisasi marang bathi resik

Simbol lan logo merek GlycoMimetics (GLYC)

GlycoMimetics, Inc. (GLYC) develops targeted anti-tumor agents, and this price chart with the -0.40 indicator reflects the aftermath of a failed key study in May 2024 and a subsequent strategic pivot. The market has already priced in the operating loss and development risks while awaiting final data on the lead candidates. Management is currently focusing on budget optimization to bring the drugs to the commercial stage.

GLYC glycomimetics.com: Koefisien rega marang bathi ing interval 04.07.2022 - 16.06.2025

Rincian metrik komprehensif lan analitis GlycoMimetics Inc. (GLYC)

- rega pasar lan target rega analis:
Rega bursa GlycoMimetics Corp|GLYC - Prakiraan konsensus analis
- indikator kapitalisasi pasar:
Kapitalisasi pasar GlycoMimetics, Inc.|GLYC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data nilai buku modal saham:
Nilai Aset Bersih saben Saham GlycoMimetics|GLYC - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku glycomimetics.com|GLYC - Gunggung Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang Agregat marang Modal GlycoMimetics, Inc.|GLYC - Utang jangka dawa marang modal|Utang jangka cendhak marang modal GlycoMimetics Corp|GLYC - Utang perusahaan|Rasio utang marang aset resik GlycoMimetics, Inc.|GLYC - Utang jangka dawa perusahaan|Tanggungan jangka cendhak GlycoMimetics|Likuiditas darurat glycomimetics.com
- data bathi bisnis lan rasio investasi:
GLYC - Penghasilan resik|Bathi resik mangsa ngarep GlycoMimetics, Inc.|GLYC - Pangali P/E|Rasio prakiraan rega marang bathi GlycoMimetics Corp|GLYC - Pangali PEG|Nilai perusahaan marang bathi operasional sadurunge panyusutan GlycoMimetics, Inc.|GLYC - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku GlycoMimetics|GLYC - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan glycomimetics.com|GLYC - Wutah bathi ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep GlycoMimetics, Inc.
Analisis komprehensif perusahaan:glycomimetics.com - GLYC
Produk dadi GlycoMimetics Inc.

The scale of developments at GlycoMimetics, Inc. (GLYC) is reflected in the dynamics of the company's market P/E ratio. This ratio correlates the current share price with net income, determining the investment payback period. This calculation allows for the identification of whether the asset is overvalued or possesses hidden potential during market shocks. The humanitarian status of medicine minimizes geopolitical risks, stabilizing the fundamental value of the business. Investors utilize this indicator to assess capital stability within safe-haven jurisdictions.

Pesaing wigati

Kapitalisasi marang bathi genmab.com GMAB|Pangali P/E EXEL|Nuvalent Inc (NUVL) - Rasio kapitalisasi marang bathi resik|Kymera Therapeutics Inc - Koefisien rega marang bathi|IDEAYA Corp (IDYA) - Kapitalisasi marang bathi|ELVN: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik ORIC (oricpharma.com)|RLAY (Relay Therapeutics, Inc.) - Koefisien rega marang bathi|NRIX: Rasio rega pasar marang bathi resik|TYRA (Tyra Bio) - Pangali P/E|Pangali P/E Verastem Corp|Rasio rega marang bathi Monte Rosa Therapeutics (GLUE)|CGEM (cullinanoncology.com) - Nilai perusahaan marang bathi resik|Pangali P/E IMRX (Immuneering)|Rasio kapitalisasi marang bathi resik C4 Therapeutics Inc|Black Diamond Therapeutics Inc. - Pangali P/E|Kapitalisasi marang bathi Repare Therapeutics Inc|PMVP (PMV Pharmaceuticals) - Koefisien rega marang bathi|KPTI: Rasio rega pasar marang bathi resik|PPCB (Propanc Biopharma Inc.) - Pangali P/E|Kapitalisasi marang bathi Bio Green Med Solution Inc. BGMS|Pangali P/E AADI|aileronrx.com - Pangali rega marang bathi|Blueprint Medicines Corporation - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik SWTX